Observational studyInvestigative ophthalmology & visual science2026
Longitudinal Assessment of Low Luminance Questionnaire Scores in Early and Intermediate AMD.
Observational study in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To characterize changes in Low Luminance Questionnaire (LLQ) scores and their correlation with visual function (VF) tests over 24 months in patients with early (eAMD) and intermediate (iAMD) AMD. Methods: We conducted a prospective longitudinal observational study of eAMD (n = 22), iAMD (n = 31), and controls (n = 17). Subjects completed the LLQ at baseline and 24 months. VF testing included best-corrected visual acuity, Early Treatment Diabetic Retinopathy and computerized low-luminance visual acuity, microperimetry, cone contrast testing, and rod intercept time (RIT). Correlations between change in LLQ scores and VF measures were assessed using Spearman coefficients. Results: Within-group differences in LLQ composite scores over 24 months were not significant in controls, eAMD, or iAMD. In an outlier analysis, subjects with a baseline LLQ composite score 2 SDs below the control baseline mean (cut off 74.2) were classified as outliers. A significant decline in composite LLQ score over 24 months was observed only in iAMD nonoutliers (median, -5.5 [minimum, maximum, -17.2, 3.1]; P = 0.008). Worsening LLQ composite and subscale scores correlated with RIT prolongation in iAMD nonoutliers. Conclusions: A significant decline in LLQ scores over 24 months was observed only in iAMD subjects with preserved baseline function. The absence of longitudinal change in the composite LLQ scores among participants with lower baseline LLQ scores suggests a floor effect. Among iAMD subjects with preserved baseline function, worsening LLQ scores correlated with RIT prolongation. This finding supports the potential utility of the LLQ as a patient-reported outcome sensitive to worsening dark adaptation. Confirmation in larger cohorts is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.